Back
Mirum Pharmaceuticals 10K Form
Sell
50
MIRM
Mirum Pharmaceuticals
Last Price:
24.07
Seasonality Move:
9.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MIRM News And Ratings
See the #1 stock for the next 7 days that we like better than MIRM
MIRM Financial Statistics
Sales & Book Value
| Annual Sales: | $186.37M |
|---|---|
| Cash Flow: | $15.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.99 |
| Price / Book: | 4.84 |
Profitability
| EPS (TTM): | -3.75950 |
|---|---|
| Net Income (TTM): | $-158.56M |
| Gross Margin: | $139.34M |
| Return on Equity: | -81.56% |
| Return on Assets: | -29.08% |
Mirum Pharmaceuticals Earnings Forecast
Key Mirum Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 4 years for MIRM is 74.76%.
- The Selling, General & Administrative Expenses for MIRM have been equal to 78.27% of Gross Profit Margin.
- The Research & Development expenses have been 55.06% of Revenue.
- The Interest Expense is -9.24% of Operating Income.
- The Net Earning history of MIRM is -87.68% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Mirum Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MIRM |
| CUSIP: | 604749 |
| Website: | mirumpharma.com |
Debt
| Debt-to-Equity Ratio: | 1.31 |
|---|---|
| Current Ratio: | 3.68 |
| Quick Ratio: | 3.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 37.53 |
MIRM Technical Analysis vs Fundamental Analysis
Sell
50
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy or a Sell?
-
Mirum Pharmaceuticals stock is rated a Sell
The current Mirum Pharmaceuticals [MIRM] share price is $24.07. The Score for MIRM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.